Rajnish Rohatgi joins Orchid AMS as Chief Executive Officer

Will lead a new, domestic division, to favourably impact Indian public health

Chennai-based Orchid Pharma has announced the appointment of Chief Executive Officer, Rajnish Rohatgi. He will be responsible for setting up a new division focused on promoting the rational use of anti-infectives, to favourably impact a key aspect of Indian public health.

Rohatgi is a seasoned leader and strategic thinker with over 35 years of experience in steering both B2C and B2B product and service businesses across sectors including consumer goods and healthcare. He has held prominent positions at prominent companies like Unilever, Max Hospital, and Becton Dickinson, where his visionary leadership and entrepreneurial acumen delivered significant impact.

Manish Dhanuka, MD, Orchid Pharma said, “Rohatgi’s appointment as CEO marks an exciting new chapter for Orchid Pharma. His wealth of experience will come handy in driving our company towards the chosen path and eventual success. We are confident that under Rajnish’s leadership, Orchid will continue to innovate, develop and grow within the competitive pharmaceutical business.”

In 2022-23 Rohatgi consulted with Orchid Pharma and was instrumental in developing a unique strategy and business plan focused on entering the domestic formulations market, with a range of antibiotics. Recognising his exceptional expertise, Orchid Pharma invited him to join full-time, undertaking the challenge of building a successful business from the ground up.

Rohatgi said, “There is a solid purpose that we will be driving  – promoting rational use of antibiotics, thereby positively impacting Anti-Microbial Resistance (AMR), a crucial aspect of Indian public health. I am looking forward to building and leading the team towards achieving new milestones and making meaningful contributions to healthcare in India.”

Backed by a string of educational foundations from IIT Kanpur and IIM Calcutta, Rohatgi has cultivated a robust foundation in propelling business growth, fostering innovation, and spearheading strategic initiatives. His appointment as CEO underscores Orchid Pharma’s dedication to excellence and its commitment to making a significant impact on the healthcare landscape in India.


Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.


Related Articles

Back to top button